Under the EUA, Jynneos can be administered either intradermally for individuals aged ≥18 years or subcutaneously for individuals aged The Food and Drug Administration (FDA) has granted emergency use ...
In a recent study posted to the bioRxiv* preprint server, researchers assessed the efficiency of a controllable self-replicating ribonucleic acid (c-srRNA) vaccine against severe acute respiratory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results